# Arbutus Biopharma Corp: Form 8-K, filed Aug 20, 2019

- Company: [Arbutus Biopharma Corp](/companies/abus.md) (CIK 1447028)
- Form: 8-K
- Filed: 2019-08-20
- Accepted by EDGAR: Aug 20, 2019, 16:09 ET
- Period: 2019-08-20
- Accession: 0001447028-19-000049
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1447028/000144702819000049/a2019-08x20x8xkforachengap.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447028/000144702819000049/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1447028/000144702819000049/a2019-08x20x8xkforachengap.htm

Filed Aug 20, 2019.
Source: SEC EDGAR, the filing index for accession 0001447028-19-000049. Last ingested by Listed: Nov 12, 2026, 17:55 ET. No prices; not investment advice.
